Vijay Pande on the Shift from Discovery to Engineering in Biology
Former a16z biotech leader Vijay Pande discusses the transformation of biology into an engineering discipline and the importance of open datasets for AI in medicine.
Pande left a16z's $4 billion biotech practice to start AI-native VZVC.
He emphasizes the shift from discovery to engineering in biology.
Open, shared datasets are crucial for AI to transform medicine.